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Survey of Current and Prior 
Pretrial Drug Testing Sites 
I. INTRODUCTION 
The national campaign to educate society about the corro-
sive effects of drug abuse has united the nation. In a recent 
national poll, 96 percent of American voters ranked the drug 
problem highest on a list of actions President Bush should 
focus on. 1 One of the most dangerous aspects of drug abuse is 
its strong link to crime.2 "[T]he National Academy of Sciences 
Panel on Criminal Careers concluded that hard drug use 
among offenders is significantly associated with a high rate of 
criminal activity."3 Accidents directly attributable to drug 
abuse cost the nation over $40 billion per year, draining public 
resources and wasting human lives.4 
With the number of drug-related arrests increasing expo-
nentially in recent years, courts are increasingly interested in 
information about arrestee's drug use to aid in making pretrial 
release decisions. In response to this interest, the National 
Institute of Justice (NIJ) has implemented urine testing pro-
grams "to identify those drug abusing defendants who pose the 
greatest threat to community safety, and to monitor their be-
havior and control their drug abuse while under the court's 
jurisdiction in a way that reduces the risk associated with drug 
abusers."5 
The pilot drug testing program began in 1984, in the Dis-
trict of Columbia (D.C.). Based on the positive results of the 
D.C. program, the Bureau of Justice Assistance (BJA) has 
1. Most People in Survey Believe; Work on Drugs, Arms, Environment, Deficit 
Most Uniformly Supported, WASH. POST, Nov. 12, 1988, at A10. 
2. Douglas A. Smith et al., Drug Use and Pretrial Misconduct in New York 
City, 5 J. QUANTITATIVE CRIMINOLOGY 101-125 (1989); George Speckart & M. Doug-
las Anglin, Narcotics Use and Crime: An Overview of Recent Research Advances, 13 
CONTEMP. DRUG PROBLEMS 741 (1986); J. BALL ET AL., THE DRUGS-CRIME CONNEC-
TIONS, THE CRIMINALITY OF HEROIN ADDICTS WHEN ADDICTED AND WHEN OFF 
OPIATES (1981). 
3. Smith et al., supra note 2, at 101. 
4. JOHN A. CARVER, U.S. DEPT. OF JUSTICE, DRUGS AND CRIME: CONTROLLING 
USE AND REDUCING RISK THROUGH TESTING (1986). 
5. !d. 
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funded pretrial urine-testing programs in six other jurisdictions 
as part of its mandate under the Anti-Drug Abuse Act of 1986. 
These jurisdictions include: (1) Phoenix, Arizona; (2) Tucson, 
Arizona; (3) Wilmington, Delaware; (4) Prince Georges County, 
Maryland; (5) Portland, Oregon and (6) Milwaukee, Wiscon-
sin.6 
In the federal system and in most state courts, the judge or 
judicial officer deciding whether to release a defendant prior to 
trial must consider two factors: the risk of flight and the risk to 
community safety.7 The focus of the pretrial release program is 
twofold: to help the judge in his mandate to increase the proba-
bility that the defendant will appear for his court appearances 
and to promote safety for the public, as well as to help the 
defendant overcome his drug problem. Research has proven 
that releasing defendants on the condition of monitoring pretri-
al drug usage (1) reduces a defendants usage of drugs and 
reduces crime, (2) conserves jail space for defendants charged 
with more serious offenses, and (3) provides standardized drug 
testing results for use by the judge in sentencing. The tradi-
tional program of releasing a defendant if he can make bail 
helps neither society's crime problem nor the defendant's drug 
problem. The bail system makes jails places for the poor not for 
the repeat criminal offenders. 
All of the federally funded jurisdictions began by modeling 
their pretrial drug testing programs after the District of Co-
lumbia. The program includes: (1) testing defendants shortly 
after arrest, and (2) periodic testing of selected defendants who 
are awaiting trial. Pretrial Drug Service programs use state-of-
the-art technology to quickly produce highly accurate drug 
tests. Statistical analysis of the test results from each site 
6. The Bureau of Justice Assistance (BJA) federal grants are for one year, to 
be renewed up to three years depending upon the jurisdiction's performance. After 
the third year, federal funding expires and the sites must appropriate local funding 
to either: (1) continue the two-fold operations; (2) narrow testing to after release; 
(3) only test in response to a judge's order; or (4) terminate testing altogether. 
Five of the seven jurisdictions which have received federal funding for their pretri-
al drug testing programs are still operating. The District of Columbia (D.C.) and 
Prince Georges County, Maryland are continuing the two-fold operations with local 
funding. Milwaukee County, Wisconsin; Portland, Oregon; Los Angeles County, 
California; and Tucson, Arizona have narrowed their operations primarily to moni-
toring defendants after release, funding the programs fully or partially with federal 
grants. Delaware and Maricopa county (Phoenix), Arizona had to terminate testing 
because of limited funds and administrative difficulties in implementation. 
7. CARVER, supra note 4, at 3. 
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helped the jurisdictions to adapt D.C.'s research to their unique 
circumstances. Research studies over the last five years have 
aided the programs in knowing which arrestees to test, what 
drugs to test for, how frequently to test, and what sanctions 
should be imposed when arrestees test positive. 
This comment examines the similarities and differences of 
the current and former pretrial drug testing programs. The 
first section presents the basic elements of each program. The 
second section discusses the differences in the programs. The 
last section reviews the trends in pretrial drug testing. 
II. ELEMENTS OF CURRENT AND PRIOR 
DRUG TESTING PROGRAMS 
With respect to each program, this section reviews eight 
basic questions: (1) when the program began; (2) how was it 
funded; (3) which arrestees (felony, misdemeanor or both) are 
tested for drugs prior to trial; (4) what drugs are tested for; (5) 
what methodology is used to test and retest urine specimens; 
(6) how are the test results reported (oral or written) to the 
judge; (7) is drug monitoring ordered as a condition of release 
random or scheduled; and (8) what are the consequences if 
monitored defendants test positive, violating their condition of 
release? 
A. District of Columbia8 
The pretrial service agency in D.C. began in 1963 with 
funding from a grant by the Ford Foundation. In 1984, the 
agency received a grant from the NIJ to implement a drug test-
ing program to research the correlation between drugs, crime 
and the effect of pretrial drug monitoring. 
Everyone arrested, either for a felony or misdemeanor, is 
tested at the jail, generally within a few hours, before they see 
a judicial officer. An adult's urine is simultaneously tested for 
five drugs,9 while juvenile's urine is only tested for four 
drugs. 10 The enzyme-multiplied immunoassay test (EMIT) is 
8. Unless otherwise noted, all information in this section is from a telephone 
interview with John A. Carver, Director of the D.C. Pretrial Services Agency (Nov. 
12, 1990). 
9. Adult arrestees' urine is tested for traces of the following five drugs: 
cocaine, opiates (heroin), PCP, methadone and amphetamines. 
10. Juvenile arrestees' urine is tested for traces of the following four drugs: 
cocaine, opiates, PCP and marijuana. 
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the standard methodology used to test all specimens and to 
retest those that tested positive. 11 If the positive is disputed, 
the agency may retest with a different technology. 12 
Before being tested, arrestees must sign a consent form. 
The pretrial services staff explains to each defendant that they 
are asking for a urine sample to test for drugs and that the 
results will only be used to help determine the defendant's 
conditions of release not as evidence of guilt in his or her tri-
al.13 Although defendants have a right to refuse to give a 
urine sample, in practice most comply.14 Refusal or inability 
to provide a sample usually results in release being conditioned 
on submitting a sample with the agency. 15 
The results of the drug test are recorded on a report which 
is given to the judge at the arraignment hearing. Because the 
report will eventually become part of the public record, the 
agency, to safeguard confidentiality, does not record which 
drug(s) the arrestees tested positive for. The record only re-
flects whether drug use was "indicated," "not indicated'' or ''undetermirurl" 
Judges have a mandate to consider an arrestees likelihood 
to appear for court and the degree of risk involved in an 
arrestees release. Because of the correlation between drug use 
and both the failure to appear and the likelihood of rearrest, 
judges routinely stipulate that defendants who initially test 
positive for one or more drugs participate in drug monitor-
ing.Is 
11. Research indicates that the enzyme-multiplied immunoassay test (EMIT) 
system has an accuracy rate of ninety-seven to ninety-nine percent when used in 
conjunction with confirming tests. Courts have found the EMIT tests presumptively 
reliable and properly admissible into evidence. See James K. Stewart, Quid Pro 
Quo: Stay Drug-Free and Stay on Release, 57 GEO. WASH. L. REV. 68, 73 (1988). 
12. The EMIT system is used at all sites for testing and for retesting, unless 
the test is being used to revoke a defendant's release, in which case they use gas 
chromatography/mass spectrometry (GC/MS). The EMIT technique costs approxi-
mately $7 compared to GC/MS which costs $80. In California a positive test can be 
used as a violation of probation, in which case the positive must be retested using 
GC/MS. 
13. D.C. PRETRIAL SERVICES AGENCY TRAINING & PROCEDURAL MANUAL 125 
(Oct. 1985). All pre-trial programs have the same procedure of obtaining written 
consent after explaining the limited use of the results. 
14. CARVER, supra note 4, at 3. 
15. ld. 
16. Initial urinalysis testing showed drug use to be far higher than the self-
reported data indicated. "Statistics show almost three-fourths of adult arrestecs and 
almost one-third of juveniles have drugs in their system when first tested-far 
more than acknowledge to pretrial services interviewers that they arc users." David 
S. Broder, D.C. Pretrial Agency Is a Small but Vital Cog in WhP<'ls of JusticP, 
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As a result of the large numbers of arrestees to be tested, 
adults are put on scheduled testing, once a week. John Carver, 
director of the D.C. Pretrial Services Agency, said it is a logisti-
cal problem to get most defendants to show up for random test-
ing.17 Juveniles are easier to contact, therefore, they are sub-
ject to random testing. 
Theoretically, arrestees could plan their drug use around 
their weekly test because of retention rates. However, those 
arrestees that are in control enough to circumvent the testing 
are probably not the ones that are a threat to society. 18 Re-
search has shown that the most dysfunctional and dangerous defen-
dants test positive even with the scheduled system. 19 
The agency provides an updated report at each defendant's 
status hearing. If the defendant is not showing up for testing or 
is continually testing positive, the judge may either intensify 
the testing or treatment, sanction the defendant, revoke the 
defendant's conditional release and set a bond, or revoke his or 
her bond and incarcerate. The court will usually allow eight 
negatives before the defendant is dropped from drug testing 
unless the judge specifies otherwise. 
The District of Columbia's program is unique in that it 
serves both the superior court system of D.C. and the federal 
court system. Another unique feature is that D.C. has a statute 
that bars the release of the test results for anything except 
setting release conditions or sentencing. Most other jurisdic-
tions only have a memorandum of understanding that prohibits 
positive drug test results from being used in guilt proceed-
WASH. POST, May 28, 1989, at C1, C4. 
17. Many of the defendants do not have phones to be contacted. If the agency 
leaves a message with the defendant's family or friends the defendant may pur-
posely not show up and use as an excuse that he did not receive the message. 
Excuses are difficult if not impossible to prove. Telephone interview with John A. 
Carver, Director of the D.C. Pretrial Services Agency (Nov. 12, 1990). 
18. !d. 
19. MARY A. TOBORG ET AL., U.S. DEPT. OF JUSTICE, ASSESSMENT OF PRETRIAL 
URINE TESTING IN THE DISTRICT OF COLUMBIA (1989). 
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ings.20 
B. Milwaukee, Wisconsin21 
The Wisconsin program received its first federal grant from 
the BJA in April 1988 and began its Drug Testing Technology 
Transfer Program (DTTT) in January 1989.22 Similar to D.C., 
the DTTT began its research and testing with two components: 
(1) initial testing to help in setting release conditions and (2) 
drug monitoring to control the risk of continual drug use as 
well as signal to the judge whether or not the defendant is a 
good candidate for probation. 
All felony defendants and serious misdemeanor defen-
dants23 were tested, generally within twenty-four hours, prior 
to the initial appearance. Using EMIT, DTTT tests for cocaine, 
amphetamines, opiates, benzodiazepines (tranquilizers) and 
marijuana. Results of the test were verbally reported to the 
judge along with a recommendation for release24. Similar to 
the D.C. program, the judge was not specifically told what 
drugs the defendant tested positive for, but only whether the 
drug test was positive. 
In April 1991, when federal funding expired, the program 
had to scale down because of limited local funds. The program 
directors decided to stop testing in the lock-up (component one) 
to save money.25 The limited funds and new technology are 
20. D.C. CODE ANN. § 1303 (1981). The statute safeguards confidentiality by 
limiting the test results use to setting and enforcing release conditions. If an 
agency keeps a record of drug test results a lot of people want to use them. For 
example, a prosecutor may want to use the results for a future charge, an attorney 
may want to use the results to discredit a criminal's testimony, or an ex-spouse 
may want to use the results in a divorce or custody proceeding. 
21. Unless otherwise noted, all information in this section is from a telephone 
interview with Bob Sayner, Assistant Executive Director of Wisconsin Correctional 
Services (Oct. 20, 1990). 
22. The Wisconsin Correctional Service (WCS) together with representatives 
from the agencies that operate and assist the program, prepared the policies and 
procedures manual. ld. 
23. A serious misdemeanor is defined as one involving offenses against persons, 
weapons charges and possession of drugs. MILWAUKEE COUNTY DRUG TESTING 
TECHNOLOGY TRANSFER PROGRAM PROCEDURAL MANUAL (DRAFI') 1 (1990). 
24. Based on the test results and other drug use indicators, the bail evaluation 
report may recommend supervised pretrial release and/or monitoring by urinalysis 
as release conditions. If an arrestee's initial test is positive, he admits using drugs 
within the past six weeks, he is currently charged with delivery of a controlled 
substance or has a prior history of drug abuse then the WCS will recommend 
urine surveillance. ld. at 3. 
25. Telephone interview with Marilyn Walczak, Director of Bail Evaluation 
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now only used to keep track of those arrestees that pretrial 
services are responsible for monitoring pending trial.26 
Drug monitoring is randomly administered, twice a week 
for felony defendants and once a week for misdemeanor defen-
dants unless the judge orders otherwise. DTTT gets around the 
logistical problems of random testing by giving the defendants 
bus tickets and requiring them to call in each day to see when 
they need to report for testing. 
A summary of each defendant's release performance is 
provided to the court to document compliance with release 
conditions. Testing and treatment is intensified if a defendant 
consistently tests positive or fails to comply with any of the 
other conditions of release.27 Bob Sayner, the Assistant Execu-
tive Director of WCS, is against reincarceration solely based on 
a defendant testing positive. It is Sayner's opinion that if the 
defendant is showing up for testing and trying to be coopera-
tive, the fact that he is having a difficult time overcoming his 
addiction is not enough to send him back to jail. Sayner be-
lieves that a defendant can test positive many times and then 
one day win the battle and stop. 
C. Maricopa County, Arizona (Phoenixl8 
Maricopa County's pretrial service agency is part of the 
Superior Court system in Arizona. The agency obtained 
their first federal grant in July 1988 and began testing four 
months later.29 In Mid-February 1992, the third and last 
year of federal funding expired and Maricopa County termi-
nated all pretrial drug testing because the government did 
(March 30, 1992). 
26. ld. 
27. If a defendant drops two consecutive "dirty urines" the DTTT tries to get 
him or her into an out-patient drug rehabilitation program. If the defendnat 
continues to test dirty then the DTTT pushes to get the defendant into an in-
patient program. The latter is difficult because most defendants that are addicted 
are also indigents and uninsured. This group is not a high priority for state 
money; pregnant women and juviniles have a higher preference. However, the 
DTTT is persistent in calling each day to check when there are openings for their 
clients. 
28. Unless otherwise noted, all information in this section is from a telephone 
interview with Tom Morrison, Director of Pretrial Services in Initial Appearance 
(Oct. 23, 1990). 
29. The planning committee which organized the program to obtain the grant 
included the Directors of Pre-Trial Services and the Criminal Court Administrator. 
!d. 
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not appropriate the necessary funds. 30 
In phase one, felons were asked to voluntarily provide 
urine samples at the jail. The specimens were sent by couri-
er to a lab to be tested for amphetamines, cocaine, opiates, 
barbituates and PCP and the test results were returned by 
courier. Although the courier would stop by the jail every 
few hours to pick up samples and return results, pretrial 
services was not getting a high percentage of results back 
before to the defendant's initial appearance.31 This defeated 
the purpose of testing because the test results were to aid 
the judge in determining release conditions. 
Initial drug test results received before the defendant's 
initial appearance, were reported on confidential agency re-
cords and were given to the judge. As is common, the re-
cord only indicated whether the defendant tested positive or 
negative for the five commonly tested drugs. A pre-trial 
agency worker who knew the actual results of the test 
would attend the hearings to provide further information to 
the judge if requested. 
If the judge decided to release the defendant, not uncom-
mon because of overcrowded jails, and the defendant initial-
ly tested positive, the judge would often set a condition that 
the defendant remain drug free and require scheduled test-
ing to monitor the defendant's compliance. Such testing was 
arranged twice a week so that defendants are unable to 
plan their drug use around the testing. 
Defendants on drug monitoring who continued to test 
positive received escalated warnings: one positive test result-
ed in a verbal warning; two consecutive positive tests re-
sulted in a written warning; and three consecutive positive 
tests or five non-consecutive positive tests could result in 
the defendant having his release revoked. 
The second phase cured the problematic delay of having 
to depend on a courier to deliver the defendants' test results 
by installing computers in the jails. This modification pro-
vided for the agency to have on-line access to the lab re-
sults. 
30. Phone conversation with Terri Jackson, Director of Pretrial Services Super-
vised Release (March 29, 1992). 
31. Arizona has a statute which requires that everyone arrested, felon or 
misdemeanor, go before a judge for an "initial appearance" within twenty-four 
hours. 
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The third phase of the program terminated initial drug 
testing because only 45% of all defendants tested positive. 
To save money Phoenix began using an "assessment profile" 
to identify defendants that need drug monitoring, rather 
than initial drug testing. If the defendant met this profile 
then pretrial services recommended monitoring. Eliminating 
the testing of all felons prior to their initial appearance 
saved thousands of dollars. The risk in this modified pro-
gram was whether the profile, which considered factors simi-
lar to those used in setting bail, would adequately identify 
the dangerous drug users. The agency decided that the 
possibility of releasing some drug abusers without monitor-
ing did not outweigh the cost and administrative hassle of 
initially testing all felons. 
In the third phase if a defendant tested negative four 
consecutive times, the defendant was dropped from sched-
uled testing, however, he or she would still be subject to 
random testing. 32 This change saved the state money and 
saved the defendant from the hassle of providing a sample 
twice a week. 
D. Multnomah County, Oregon (Portland/3 
Portland received a grant from the federal government for 
pretrial testing and monitoring in July 1987 and began 
operations in January 1988.34 The county division adminis-
tered pretrial drug testing from January 1988 through July 
1989. In July 1989, the division stopped initial drug testing 
in jail and began monitoring defendants only after their re-
lease. Drug testing stopped altogether in June 1990 when 
the three years of federal grant money ended. The division 
then applied for and was awarded funds to continue the 
program. 35 Portland is now in its forth year of testing and 
its federal grant money will expire February 28, 1993. The 
county had not finalized its budget for the fiscal year run-
32. Statistics indicate that after four negative tests there is only a five percent 
probability that the defendant will test positive again. Morrison, supra note 25. 
33. Unless otherwise noted, all information in this section is from telephone 
interviews with Cary Harkaway, Division Manager of Diagnostic and Program 
Development (Oct. 24, 1990 & April 1, 1992). 
34. The committee that helped plan the drug testing included the: state courts, 
community corrections department, sheriff, district attorney's office, laboratories and 
pre-trial service agency itself. Id. 
35. The agency was awarded a "Do Grant." 
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ning from July 1992-93 so the division does not know 
whether it will be supported by county funding after Febru-
ary of 1993 or whether the resources will not be available 
again, forcing testing to stop. 
For the first two years all felons and misdemeanors were 
tested for opiates, cocaine and amphetamines within a few 
hours of arrest. The third year only felons were tested. The 
samples were taken at the jail and sent to a lab where the 
EMIT test results were immediately input on the computer 
system which the division had access to. The test results, 
positive or negative, were provided in writing to the arraig-
nment court, making drug use part of the public record. 
Generally, the division monitored those defendants who 
were released prior to trial, with the condition of drug mon-
itering, once a week using random drug tests.36 For the 
first year and a half of the program, defendants were on a 
color code system. Defendants were assigned a color and 
had to call in each day and hear a taped message that 
would inform them which color had to go to the lab that 
day to be tested. The next year and a half, defendants 
would call their caseworker to find out whether they should 
come to the agency to be tested that day. The later system 
worked better because case workers had more control over 
defendants to cause them to show up. However, it was 
expensive. 
The division created a new system the fourth year com-
bining the prior two systems. To be cost efficient, each 
defendant is assigned a number (1-6) and required to call 
each day to see if their number has been chosen that day 
to be tested, similar to the color code system. The case-
worker need only contact the defendant if he or she did not 
show up for testing. There is little tolerance for no-shows. 
Mter two no-shows the defendant will have a hearing and 
may get jail time or a revocation of his or her release. 
Mter the third or fourth consecutive positive test result, 
the case worker will schedule a "show cause hearing" in 
which the defendant will report on his or her progress. The 
judge has discretion to intensify the testing, recommend 
36. Drug monitoring is determined by the agency, not by judges. 
The Chief Criminal Judge in Portland made a blanket order that everyone who 
meets the pretrial service agency's requirements is subject to drug monitoring as a 
condition of his release. 
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treatment, put the defendant in jail for two to five days or 
any combination. Generally, the defendant's release will not 
be revoked if he or she is appearing for testing and meeting 
the other conditions. On the other hand, if the defendant 
continues to test clean, tesing will decrease from weekly to 
by-weekly until the defendant can be free from testing, 
opening up a slot for another client.37 
Beginning in 1991, the division changed its policy from 
pre-arraignment testing of felons to only testing those felons 
who meet certain "risk" criteria that are either released to 
pretrial services or on probation.38 Cary Harkaway, Divi-
sion Manager of the program, believes pre-arraignment drug 
testing is good for some communities but he believes that it 
is not cost effective for Portland. This belief is backed with 
research reporting that only six percent of the defendants 
who tested positive on their initial drug test were regular 
drug users. 
The 1991 program is set up to focus agency resources on 
those with the greatest need for monitoring. The primary 
goal of the program is to effectively identify felons with a 
serious substance abuse problem and provide intervention 
through counseling or more intensive treatment to help 
them avoid a revocation of their release. The division does 
not want to test more people than it can effectively sanction 
or treat. Admittedly, this program may not identify all drug 
users, but the city can't treat all drug users either. 
E. Prince Georges County, Maryland39 
Maryland obtained federal funding in April 1988 and be-
gan pretrial drug testing in July of the same year. Mary-
land is now in its first year of local funding. AI Hall, the 
director of the department of corrections, reports positive re-
sults with Maryland's program and has continued pretrial 
drug testing at the same level as it did during the three 
year pilot program that was funded with Federal grants. 
Only arrestees that do not make bond must be tested for 
drugs. Testing is generally performed within twelve hours 
37. The Division has also allocated resources for spot check drug testing. 
38. Currently, 85% of testing is post-trial with only 50 slots available for pre-
trial testing. 
39. The information for this section, unless otherwise noted, is from a telephone 
interview with AI Hall, Director of Pretrial Services (Oct. 25, 1990). 
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after the arrest. An arrestee is brought before a commis-
sioner40 who notifies the defendant of the charges, reviews 
the defendant's rights and decides to set bond or incarcer-
ate. Defendants, who fail to make bond, are sent to the 
Department of Corrections (DOC). The DOC then tests all 
defendants for drugs and recommends release conditions 
based on the defendant's test results and other factors. 
Originally, defendants were tested for cocaine, PCP, opi-
ates, marijuana and methadone. Methadone was dropped 
within two weeks because no defendant tested positive for 
it. Amphetamines were then added, but were also quickly 
dropped for the same reason. For cost efficiency, testing for 
marijuana was also dropped after the first year. Every de-
fendant that tested positive for marijuana also tested posi-
tive for another drug. Presently, defendants are tested for 
cocaine41 , PCP and opiates. The DOC has been using 
the Abbott-ABX unit for testing but is changing over to 
EMIT to reduce cost. Positive results from the initial test 
are not confirmed. The rationale is that the initial test is 
only a preliminary test to help the judge set release condi-
tions. A positive initial test will only cause the judge to 
recommend drug monitoring but will not prohibit the defen-
dant from being released. 
If the defendant tests positive on release pending trial he 
has three options. He may either admit that the test is 
correct, deny that it is correct or refuse to comment. A 
positive test must be confirmed if the defendant does not 
admit that he has used drugs. Confirmed positive tests are 
reported to the judge if the defendant is charged with a vio-
lent crime or after the third violation if the defendant is 
charged with a non-violent crime. 
The DOCs drug monitoring records are kept confidential 
by a computer security system. Test results are only re-
leased to the judge if the defendant violates his release 
conditions by testing positive one to three times, as dis-
cussed above. It is then up to the judge's discretion whether 
the test results indicating the defendant's drug usage is put 
in the defendant's public file. 
Maryland has four levels of supervision. All defendants 
40. The commissioner is considered a judicial officer but generally has no legal 
background. !d. 
41. 96% of defendants test positive for cocaine. !d. 
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begin on level one, which can monitor an unlimited number 
of defendants, and are tested once a week on specific 
days.42 If a defendant continues to test positive then he is 
moved to level two and testing is increased to two or three 
times weekly. If the defendant still does not control his 
drug problem or otherwise violates his release conditions, he 
is moved up to level three or four, if there are open slots, 
in which he either receives daily visits from his case worker 
or has an electronic tracing device placed on him for contin-
ual monitoring. If there are no openings in level three or 
four and the defendant continues to test positive, the judge 
may reincarcerate for three to five days and then reissue a 
new contract of conditions. If the defendant violates the new 
conditions he will be reincarcerated until trial. 
F. Los Angeles County, California (L.A./ 3 
Los Angeles County began pretrial drug testing of felons 
in April 1990, on a phase in basis.44 The program is fund-
ed with $500,000 in federal grants and $300,000 in county money. 
Prior to their bail hearing, approximately six days after 
they are arrested, most defendants are released to the pre-
trial services agency. The agency assesses whether the felon 
is a likely drug user requiring drug monitoring based on his 
prior criminal history, the crime charged and other available 
information. Then, if testing is recommended, the agency 
performs a risk assessment on the defendant to determine 
how often testing should occur.45 Selected defendants are 
tested for five drugs: cocaine, opiates, PCP, barbiturates and 
42. Because of the physical location of the jail, Maryland gives the defendants 
specific days that they must come in to be tested. Although Prince Georges Coun-
ty, Maryland is a major metropolitan area, the jail is in a rural area which is 
difficult to get to. Defendants must arrange rides or take public transportation, 
therefore, they are given adequate notice to get there. ld. 
43. Unless otherwise noted, the information for this section is from a telephone 
interview with Terry Clark, Assistant Director Pretrial Services Division (Oct. 23, 
1990). 
44. The committee which participated in fashioning the drug testing procedures 
included the Presiding Judge for the Los Angeles Municipal Court, the Chairman 
of the Presiding Judges Association, the Area Commissioner for the Sheriffs De-
partment, the Director for Bureau of Central Operations for the District Attorneys 
Office, the Chief Probation Officer for the Probation Department, the Chief Medical 
Examiner for the Coroners Office, the Director of Criminal Court Operations and 
the Assistant Director for Pre-trial Services. ld. 
45. The court has given pretrial services blanket authority to test felons accord-
ing to the agency's risk assessment. 
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amphetamines. The method of testing used is Radio-Immu-
noassay (RIA). Positive tests are confirmed upon request 
using gas chromatography/mass spectrometry (GC/MS). 
Pretrial services uses the color code system to randomly 
monitor the selected felons. The frequency of testing is de-
termined by whether the positives are escalating or decreas-
ing. If the defendant continues to test "dirty," the frequen-
cy is escalated; if the defendant continues to test clean, the 
frequency is decreased. Defendants who test positive are 
given a verbal warning after the first positive, followed by a 
written warning for a second positive test result. A third 
positive test result requires the defendants to go for treat-
ment and after four consecutive positive tests, their release 
may be revoked. 
Progress reports for each defendant on the pretrial re-
lease program are submitted to the court at each court 
appearance. The reports do not become part of the public 
record but are placed in the defendant's confidential court 
file, not to be released without a court order. The district 
attorney and the prosecutor also receive a copy of every-
thing submitted to the court. 
The district attorney is under an agreement that a posi-
tive drug test cannot be used for additional charges. Howev-
er, the probation department can use a positive drug test as 
a violation to revoke probation if the defendant is on an 
active grant of probation with a drug prohibition. Positive 
test results are not released to the probation department 
until the case is complete. 
According to Terry Clark, Assistant Director, Pretrial Ser-
vices Division, the L.A. program has accomplished its pur-
pose. The problems with the program stem from the large 
number of court districts the agency has to work with. 
There are twenty-five municipal court districts and every 
judge has his own opinion of what works and what does 
not. Communicating the agency's rationale for the proposed 
conditions of release or the proposed sanctions for failure to 
comply with the release conditions, according to each courts' 
preference, creates confusion. L.A. is now in the process of 
looking at the concurrence rate as to whether the judge 
follows the agency's recommendation to see what they can 
do to improve it.46 
46. Telephone interview with Ralph Rodgers, Senior Investigator at Pretrial 
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G. Pima County, Arizona (Tucsoni 7 
Tucson began fullscale pretrial drug testing in October 
1987 and has had to repeatedly scale down testing because 
of limited funds. The first three years was entirely funded 
with federal grants from the Department of Justice. As is 
typical, modifications of the program, including what drugs 
were tested for and when testing occurred, ensued after 
each year, 
During the first year, all felony defendants were tested 
for five drugs, four standard drugs (marijuana, cocaine, 
opiates and amphetamines) and one rotating drug (rotated 
barbiturates and benzo-diazaphine). Low results prompted 
the agency to stop testing for marijuana and the two rotat-
ing drugs after the first year. 
During the first two years, the defendant was tested for 
drugs prior to his initial court appearance so that the re-
sults of the test could be incorporated in a recommendation 
to the judge. The judge, prosecutor and defense counsel 
were notified if the defendant initially tested positive. If the 
judge wanted to know what drug the defendant had been 
using, an agent from pre-trial services attending the hearing 
would provide the requested information. Pretrial services 
would also file a notice with the court every time the defen-
dant tested positive and send a similar notice to the prose-
cutor and the defense counsel. The court had discretion on 
whether this information became part of the public record of 
the hearing, depending upon whether the judge put the 
notice on file. 
During the third year of the program, the agency disc on-
tinued drug testing prior to the initial appearance and 
switched to using a risk assessment scale to determine 
whether they would recommend a defendant be monitored 
for drug usage pending trial. The whole process went more 
smoothly as the bugs worked out during the third year, but 
the agency was forced to drastically reduce testing when the 
federal funds ran out. Cost was the primary reason given 
for narrowing pretrial drug testing to only those defendants 
Services (Mar. :10, 1992). 
47. The information in this section is from a telephone interview with Kim 
Holoway, Director of Pretrial Services (Oct. 23, 1990). 
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who have a known drug problem. In July of 1991 the pro-
gram again was scaled down because of limited local fund-
ing. The funding went from $15,000 to $2,000. Now only 
defendants with known drug problems that are thought to 
be problematic are monitored. Ms. Holaway, the Director of 
Pretrial Services, said the cutback in funding was strictly a 
financial issue; the commissioners and judges supported the 
program.48 
H. Harris County, Texas49 
Drug testing in Harris County began in 1985 in one 
court, with seventy-five percent of the funds coming from 
the Law Enforcement Administration Association (LEAA) 
and the balance from county funds. It now operates exclu-
sively on local funds, with the majority of courts participat-
ing in drug monitoring pending trial. 50 What is most 
unique about Harris County drug testing is that there are 
no written procedures for pretrial drug testing. The courts 
have discretion to require any defendant to be tested as a 
condition of release and monitored while on release. 
Following arrest, each case is reviewed by the district at-
torney. If charges are filed, if bond is set, and if the defen-
dant cannot make bond, there is a hearing, generally within 
twenty-four hours, in which the judge decides under what 
conditions the defendant can be released without bond. De-
fendants are only tested for drugs if a court mandates test-
ing or monitoring as a condition of release. 
All thirty-six courts in Harris County use different crite-
ria for setting release conditions. In one court, everyone 
released must be tested for drugs, whether charged with a 
felony or a misdemeanor. In some courts, defendants are 
tested if they are arrested for any of five charges. In other 
courts, judges make a probability assessment which consid-
ers the defendants drug history, criminal charge, probation 
records, and other known information. If defendants do not 
48. Telephone interview (Mar. 29, 1992). 
49. The information in this section is from a telephone interview with Carol 
Oeller, Director of Pretrial Services (Oct. 29, 1990). 
50. The average number of defendants screened per month in 1989 was fifty-
eight. One thousand four hundred and forty-two specimens were tested with two 
hundred and twenty-nine confirmed positive tests. Sixty-eight of the defendants 
tested positive for cocaine. Id. 
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consent to the court mandated testing, they are not re-
leased. 
Selected defendants are tested for cocaine, amphetamines, 
opiates, PCP, barbiturates, methadon and marijuana. The 
method used for testing is the standard EMIT. If the test is 
positive, the medical examiners office, which receives the 
samples and performs the testing, retests using both GC/MS 
and TLC to confirm. This ensures that reincarceration or 
revocation of probation is deserved. 
Typically, judges require defendants to be monitored twice 
weekly. If the test is positive the judge is verbally notified 
of which drug(s) the defendant tested positive for. 51 Defen-
dants are allowed to test positive for a week or so to let 
the drugs work out of their system. If defendants test posi-
tive after the first week then they are sent back to jail. 
The agency has tried to work with the judges recommending 
increasing sanctions for defendants who consistently test 
positive, however, judges in Harris County do not believe in 
graduated sanctions. 
Ill. DIFFERENCES IN THE PRETRIAL DRUG TESTING PRO-
GRAMS 
Although all six of the pretrial drug testing programs, 
except Harris County, began following the D.C. model, each 
county has modified their program primarily because of re-
search and budget limitations. Differences in interpretation 
include: (1) who is tested; (2) which drugs are tested for; (3) 
the method used for testing and retesting if positive; ( 4) at 
what stage arrestees are tested; (5) whether monitoring is 
scheduled or random; (6) how the drug monitoring results 
are reported to the judge; and (7) what sanctions the judge 
imposes for testing positive.52 
A. Who is Tested 
Unlike the D.C. model that tests all arrestees, four of the 
five jurisdictions (Los Angeles, Tucson, Portland, and Mil-
51. For confidentiality reasons nothing in writing is submitted to the judge and 
the pre-trial service records with the drug testing results are kept confidential. 
However, if the defendant is reincarcerated the prosecutor and defense council 
usually know why. ld. 
52. Harris County is not included in the summary of differences because it is 
not a federal pilot project and has no written polices and proeedures 
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waukee) test only felons. 53 The reasoning is that felons 
have a higher probability of rearrest and skipping town. 
Jurisdictions that have limited funds must focus on those 
with the highest probability of committing future offenses. 
B. What Drugs are Tested For 
The goal in pretrial drug testing is to find which drugs 
in the area are most abused and then to test defendants for 
those drugs. To reduce the cost, jurisdictions screen different 
drugs and drop those tests which defendants rarely test 
positive for. 54 D.C. tests for five drugs: cocaine, opiates, 
amphetamines, PCP and methadone. All five of the juris-
dictions test for cocaine and opiates. In addition, four of the 
five test for amphetamines and two test for PCP.55 Other 
drugs tested for include marijuana,56 benzo-diazephines,57 
and barbiturates.58 
C. Method Used for Testing and Retesting 
D.C. uses EMIT, as does four of the five jurisdictions,59 
as the standard method of testing because of its cost effi-
ciency. EMIT costs approximately eight dollars per test. In 
contrast, GC/MS, generally used by large corporations, costs 
approximately eighty dollars per test. Although EMIT is less 
accurate, EMIT is 95% accurate compared to GC/MS which 
is 99% accurate, such a difference is not crucial when the 
court is only testing to decide whether drug monitoring is 
appropriate. If the test is disputed or if it is used for revok-
ing a defendant's release or probation, all of the jurisdic-
tions, except D.C., use another methodology to retest, gener-
ally GC/MS. 
D. Scheduled or Random Testing 
53. Maryland tests everyone that fails to make bond. 
54. The average number of drugs tested for is three. Los Angeles and Milwau-
kee test for five drugs. 
55. Los Angeles, Portland, Milwaukee and Tucson test for amphetamines. Los 
Angeles and Maryland test for PCP. 
56. Milwaukee only. 
57. Milwaukee only. 
58. Los Angeles only. 
59. Los Angeles uses Radio-Immunoassay (RIA) to test and GC/MS to confirm 
positive tests if requested. 
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Because of the large numbers of defendants tested in 
D.C., because of the test location in Maryland, and because 
of limited funds in Tucson, testing is done on a regular 
schedule. The drawback of using a schedule is that some 
defendants may circumvent the system by planning their 
drug usage around the tests. Jurisdictions, however, must 
weigh practicality against the chance that some defendants 
may evade the system. 
Three of the five jurisdictions are able to use random 
monitoring which is the most effective. Los Angeles random-
ly monitors defendant,s drug usage using the color code 
system, requiring defendants to call in each day to see 
which color must report that day for testing. Portland uses 
a number system similar to the color code system, requiring 
defendants to call in each day to see which number must 
report for testing. Wisconsin randomly tests defendants by 
giving them a monthly bus ticket and requiring them to call 
in each day to see whether they need to come in and be 
tested. 
E. Reporting Test Results to Judges 
All of the jurisdictions report, either verbally or in writ-
ing, whether the presence of specific drugs were found in a 
defendant's urine by using the general phraseology: subs-
tance abuse is "indicated," "not indicated" or "undetermined." 
If the judge wants to know what the defendant tested posi-
tive for, he can ask an agent of pretrial services. Typically, 
however, the judge is only concerned with whether the de-
fendant is using drugs not what particular drugs he is us-
ing. 
The District of Columbia and Portland give the court a 
written report of each defendant's drug tests. Because the 
report becomes public record, the specific drugs which the 
defendant tested positive for are not included on the report 
for confidentiality reasons. Los Angeles and Maryland also 
submit written reports to the judge, however, the report, in 
these places, does not become part of the public record. 
Wisconsin and Tucson have stricter confidentiality require-
ments, which require the test results to be verbally reported 
to the judge. This helps to ensure that the test results are 
not used improperly. 
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F. Sanctions for Testing Positive 
Jurisdictions are split on how to implement sanctions 
against defendants who continue to test positive. Three of 
the counties believe defendants must stop "cold turkey," in 
contrast to the other two who believe defendants should not 
be punished for testing positive if they are trying to stop 
and are having a difficult time. 
The District of Columbia, Los Angeles, and Tucson have 
escalating sanctions for defendants who continue to test 
positive. Initially, defendants are given a grace period of a 
week to ten days to get the drugs out of their system. Mter 
the grace period, defendants typically receive a verbal warn-
ing after the first positive, a written warning after the 
second positive, intensified testing and or a recommendation 
for treatment after the third positive and a request for a 
show-cause hearing60 after the fourth or fifth positive. 
Courts in Portland and Wisconsin are more lenient in 
their sanctioning of defendants monitored on release. If the 
defendants are appearing and testing positive, the courts 
will encourage the case workers to continue to work with 
the defendants and try to get them into treatment. If defen-
dants are not appearing for testing or otherwise violating 
release conditions and testing positive, the judge may revoke 
the release. Research has shown that it may take weeks for 
a defendant to overcome a drug addiction even if he is 
trying. A defendant may, therefore, test positive for weeks 
until he can get enough control to stop. 
IV. TRENDS IN PRETRIAL DRUG TESTING 
All of the federally funded pretrial drug testing programs 
initially involved two components: (1) a drug test after ar-
rest, while the defendant is in custody prior to arraignment, 
and (2) drug testing as a condition of release for defendants 
with indications of drug use. 61 Four of the five jurisdictions 
following the D.C. model have terminated the initial drug 
test, believing it more cost effective to focus resources on 
60. In a show-cause hearing a defendant must show why he should not be 
reincarcerated. 
61. Indications of drug use include: positive test in custody, self-report, drug 
history or current drug charges. 
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drug monitoring. Only Maryland has continued the initial 
drug test, which it believes significantly helps judges set 
release conditions for safeguarding the community. 
The jurisdictions that have discontinued the first compo-
nent claim that initial drug testing is not as useful in iden-
tifying drug users as it is in identifying what the offender 
population is using and to what extent. Those jurisdictions 
advocate that pretrial services should perform initial tests 
for about a year to leam what to test for and how frequent-
ly to test and then terminate the first component and focus 
all of the resources on the second component to expand 
limited treatment facilities. 
If states could expand their treatment facilities, they 
could help defendants overcome their addiction rather than 
just deter their usage with testing. In most communities 
there are long waiting lists for treatment services, making it 
difficult to provide defendants with counseling for drug 
abuse prior to trial. States should also work on ex-
panding jail capacity to provide room for defendants who 
are reincarcerated because they continue to test positive. 
Defendants who have their release revoked because they 
continue to test positive and then are re-released within 
twenty-four hours because of insufficient jail capacity cannot 
be expected to take the sanction seriously. 
Those who support continuing use of drug testing prior to 
arraignment assert that the cost62 of performing initial 
drug testing is worthwhile because it provides information 
that is valuable in determining which arrestees are at high 
risk of pretrial misconduct.63 ''Without testing, drug use by 
arrested suspects is at best difficult. Research in New York 
City shows that only about half of the arrestees who test 
positive admit in confidential interviews to recent drug 
use."64 Studies have also indicated that "risk assessment 
factors," such as a criminal record for drug abuse, do not 
distinguish between defendants that are casual drug users, 
62. "The average cost per day in jail in 1987 for one inmate was approximately 
fifty-seven dollars, whereas the average cost of a drug test was approximately 
eleven dollars. Pretrial drug testing puts judges in a position to release a larger 
percentage of the defendants under less risky conditions." Stewart, supra note 10, 
at 76. 
63. Christy Visher, Using Drug Testing to Identify High-Risk Defendants on 
Release: A Study in the District of Columbia, 1R J. OF CRIM. JUST. 321 (1990). 
64. Stewart, supra note 10, at 69. 
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distinguish between defendants that are casual drug users, 
whose pretrial misconduct risk is low, and defendants that 
are periodically using two or more drugs and tend to be 
more dangerous. 65 Results from statistical studies on the 
association between urine test results and pretrial miscon-
duct show that drug tests do provide information that is 
associated with pretrial misconduct over and above the in-
formation typically available to judges.66 Because drug use 
correlates so strongly with increased risk of flight and risk 
to community safety, it is important that judges have infor-
mation regarding a defendant's drug use by testing the 
defendant's urine after arrest and prior to release.67 The 
director of the D.C. program, John Carver, is the strongest 
supporter of initial drug testing of all defendants. Judges 
are also strong supporters of the two part program, initial 
drug testing and systematic drug monitoring. Judges are 
more willing to release defendants who might previously 
have been detained on high bond if the judge had suspected 
drug use (e.g., due to a drug-related charge or history of 
drug abuse) on the condition of participation in a monitoring 
program, with the frequency determined by the results of 
the initial drug test. 
Preliminary findings show that monitoring defendants' 
drug use has been a strong deterrent to drug abuse, both 
during the pretrial period and as a probation condition.68 
Accordingly, more jurisdictions should be allocating funds for 
drug testing and monitoring and tracking the results. Unfor-
tunately, jurisdictions have not been allocating funds. Be-
cause of the recession's effect on counties, jurisdictions have 
had to scale back or phase out their pre-trial and in some 
cases also their post-trial testing programs. The trend may 
be to replace the bail system with a pretrial release system 
better able to monitor and help defendants with drug prob-
lems, but the ability to apply this research and reap the 
results may have to wait for an upswing in the economy. 
65. ld. 
66. Persons testing positive for heroin or cocaine have a higher probability of 
failure to appear, while those testing positive for PCP are significantly more likely 
to be rearrested. Smith et al., supra note 10, at 123-24. 
67. CARVEH, supra note 4, at 3. 
68. Stewart, supra note 10, at 74. 
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V. CONCLUSION 
Research has shown that defendants commit crimes at 
much higher rates during periods when they are actively 
using drugs than during times when they are drug free. 
Acting on this research, the NIJ implemented seven urine 
drug testing pilot programs. These programs rest on the 
hypothesis that the risk of pretrial misconduct can be re-
duced if defendants who use drugs can be identified at ar-
rest, their release conditioned on the requirement to remain 
drug free, and their compliance with that condition moni-
tored by mandatory drug testing during the pretrial release 
period. In each county the judiciary has supported both 
initial drug testing and drug monitoring. 
Independent analysis of the District of Columbia pro-
gram's results along with the other five jurisdictions still 
testing indicates that systematic pretrial drug testing does 
decrease the risk of defendants' pretrial misconduct (i.e., 
failure to appear for hearings and rearrest pending trial). 
This is due in part to the test which enables the agencies 
to detect illicit drug use quickly and intervene expeditiously. 
Further, approximately two-thirds of the defendants assigned 
to the testing stayed with the program and overcame their 
drug problem. 
Evidence of a strong correlation or relationship between 
pretrial drug testing and a reduction of pretrial misconduct 
is the foundation for the NIJ's recommendation to the Presi-
dent. The President, in his National Drug Control Strategy 
encourges adoption of drug testing programs throughout the 
criminal justice system. 
Cynthia Durrant Jensen 
